Internal Medicine, Nephrology · Hampton, VA
NPI
1932205739
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
501 Butler Farm Rd, Ste. I
Hampton, VA, 23666
Phone (757) 251-7469
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
6,263 services
Medicare patients, 2024
440
Average age 72
Drug cost, 2024
$371K
2,092 prescriptions
Company payments, 2025
$541
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olayiwola B Ayodeji was code Q5106 (injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units), 980 times for 15 patients. In total Olayiwola B Ayodeji billed 6,263 services in 36 codes, and Medicare paid $162K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 980 | 15 | $5.67 | $5,559 |
| 99214 Office E&M - Established | Office | 299 | 136 | $48.29 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 261 | 127 | $12.26 | $3,200 |
| 90960 ESRD Related Services (not dialysis) | Office | 259 | 106 | $262.97 | $68K |
| 99232 Hospital E&M - Subsequent | Facility | 230 | 112 | $58.86 | $14K |
| 90935 Hemodialysis | Facility | 119 | 65 | $51.13 | $6,085 |
| 90966 ESRD Related Services (not dialysis) | Office | 111 | 43 | $213.10 | $24K |
| 36415 Venipuncture Blood Collection | Office | 52 | 40 | $8.65 | $450 |
| 99222 Hospital E&M - Initial | Facility | 43 | 42 | $96.75 | $4,160 |
| 99213 Office E&M - Established | Office | 41 | 30 | $63.65 | $2,610 |
| 99223 Hospital E&M - Initial | Facility | 39 | 39 | $131.97 | $5,147 |
| 81001 Clinical Chemistry | Office | 37 | 32 | $3.11 | $115 |
| 81003 Clinical Chemistry | Office | 36 | 27 | $2.20 | $79.2 |
| 96372 Injection Administration | Office | 25 | 14 | $10.60 | $265 |
| 99215 Office E&M - Established | Office | 24 | 18 | $76.21 | $1,829 |
By year: 2022 $197K for 4,756 services; 2023 $180K for 4,390 services; 2024 $162K for 6,263 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 52 | 40 | $8.65 | $450 |
| 81001 Clinical Chemistry | 37 | 32 | $3.11 | $115 |
| 81003 Clinical Chemistry | 36 | 27 | $2.20 | $79.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Olayiwola B Ayodeji prescribed most often to Medicare patients was Losartan Potassium, with 160 prescriptions and refills. In total Olayiwola B Ayodeji wrote 2,092 Medicare prescriptions that cost $371K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 160 | 421 | 51 | $1,565 |
| Prosol Parenteral Amino Acid 20% No.1 | 149 | 149 | Under 11 | $27K |
| Amlodipine Besylate Generic | 121 | 335 | 43 | $570 |
| Calcitriol Generic | 115 | 302 | 37 | $1,058 |
| Sevelamer Carbonate Generic | 100 | 167 | 41 | $18K |
| Furosemide Generic | 93 | 223 | 31 | $710 |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 81 | 81 | Under 11 | $28K |
| Hydralazine Hcl Generic | 76 | 194 | 26 | $1,021 |
| Carvedilol Generic | 70 | 166 | 18 | $419 |
| Calcium Acetate Generic | 54 | 88 | 15 | $4,951 |
| Metoprolol Succinate Generic | 51 | 131 | 16 | $994 |
| Doxazosin Mesylate Generic | 45 | 119 | 14 | $483 |
| Lisinopril Generic | 41 | 73 | Under 11 | $89.73 |
| Potassium Chloride Generic | 39 | 85 | 17 | $957 |
| Clinisol Parenteral Amino Acid 15% No.5 | 38 | 38 | Under 11 | $6,591 |
Brand drugs: 411 claims; generic drugs: 1,681 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olayiwola B Ayodeji $541 ($541 in general payments such as food, travel and fees) from 10 companies. The largest payer was Scpharmaceuticals Inc. with $102.
| Company | Payments | Amount |
|---|---|---|
| Scpharmaceuticals Inc. SCPH | 5 | $102 |
| Ardelyx, Inc. ARDX | 4 | $97.12 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $90.39 |
| Akebia Therapeutics Inc AKBA | 3 | $81.88 |
| Amgen Inc. AMGN | 2 | $46.64 |
| GlaxoSmithKline, LLC. GSK | 2 | $40.96 |
| Fresenius USA Marketing, Inc. | 2 | $40.74 |
| Novo Nordisk Inc NVO | 1 | $21.45 |
| Mannkind Corporation MNKD | 1 | $19.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.